Correlation Between Alto Neuroscience, and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Alto Neuroscience, and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Tarsus Pharmaceuticals.
Diversification Opportunities for Alto Neuroscience, and Tarsus Pharmaceuticals
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Alto and Tarsus is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Alto Neuroscience, is expected to generate 1.09 times more return on investment than Tarsus Pharmaceuticals. However, Alto Neuroscience, is 1.09 times more volatile than Tarsus Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 431.00 in Alto Neuroscience, on October 28, 2024 and sell it today you would earn a total of 39.00 from holding Alto Neuroscience, or generate 9.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alto Neuroscience, vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Alto Neuroscience, |
| Tarsus Pharmaceuticals |
Alto Neuroscience, and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alto Neuroscience, and Tarsus Pharmaceuticals
The main advantage of trading using opposite Alto Neuroscience, and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Alto Neuroscience, vs. IPG Photonics | Alto Neuroscience, vs. Keurig Dr Pepper | Alto Neuroscience, vs. Globalfoundries | Alto Neuroscience, vs. Primo Brands |
| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |